Dow Up0.00% Nasdaq Up0.09%

Infinity Pharmaceuticals, Inc. (INFI)

15.01 Down 0.23(1.51%) Nov 28, 1:00PM EST
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):2.2
Mean Recommendation (last week):2.2

* (Strong Buy) 1.0 - 5.0 (Sell)

Price Target Summary
Mean Target:18.67
Median Target:19.00
High Target:24.00
Low Target:15.00
No. of Brokers:9

Data provided by Thomson/First Call

Upgrades & Downgrades History
DateResearch FirmActionFromTo
Nov 21, 2012RBC Capital MktsInitiated Outperform
Aug 24, 2012Stifel NicolausInitiated Hold
Apr 16, 2009Roth CapitalDowngradeHoldSell
Apr 15, 2009Rodman & RenshawDowngradeMkt OutperformMkt Perform
Dec 11, 2008Roth CapitalDowngradeNeutralHold
Oct 31, 2008Susquehanna FinancialUpgradeNeutralPositive
Oct 31, 2008Roth CapitalUpgradeHoldBuy
Jul 31, 2008Roth CapitalDowngradeBuyHold
Jun 6, 2008Rodman & RenshawUpgradeMkt PerformMkt Outperform
Jan 15, 2008Roth CapitalInitiated Buy

More Upgrades & Downgrades for INFI

Data provided by - Take a free trial
Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy3333

Data provided by Thomson/First Call

Currency in USD.